Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor alpha (FR alpha)-positive cancer K. N. Moore, D. Lorusso, A. Oaknin,S. Pignata,H. Denys,N. Colombo,T. Van Gorp,J. Konner,M. Romeo Marin,P. Harter,C. Murphy, Y. Tu, F. Zhu, B. Esteves,M. Method,M. J. Birrer,R. L. Coleman, U. A. Matulonis,D. O'MalleyAnnals of Oncology(2022)引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要